Catalyst Wire Dossier Catalyst Wire Dossier

IDV/r

idarucazide/ritonavir
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IDV/r, covering 2020-07-17 to 2020-07-17. Get the full timeline:

Most recent: Clinical Trial Update: The Pharmacokinetics and Safety of IDV/r With NRTIs in HIV/TB Co-infected Patients Receiving Rifampicin [Phase 1, Phase 2]

See pricing